Guggenheim Upgrades MacroGenics (MGNX) to Buy
Tweet
Share
E-mailGet Alerts MGNX Hot Sheet
Price: $4.15 +0.73%
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 7 | New: 37
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 7 | New: 37
Join SI Premium – FREE
Guggenheim analyst Charles Zhu upgraded MacroGenics (NASDAQ: MGNX) from Neutral to Buy with a price target of $12.00.
For an analyst ratings summary and ratings history on MacroGenics click here. For more ratings news on MacroGenics click here.
Shares of MacroGenics closed at $6.37 yesterday.
You May Also Be Interested In
- Cantor Fitzgerald Upgrades Omeros Corp. (OMER) to Overweight, 'We May Have Underestimated Yartemlea'
- Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold
- Citizens Upgrades Quince Therapeutics Inc. (QNCX) to Market Outperform
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
